What are the potential benefits and risks of testosterone therapy as you age?
Testosterone therapy is prescribed for clinically confirmed hypogonadism, but age-related hormone changes require careful evaluation. In this episode, we explain when testosterone treatment may be appropriate in Europe — and when it is not.
In this episode, we cover:
• What testosterone does (muscle mass, bone density, libido, red blood cell production)
• Age-related testosterone decline vs pathological hypogonadism
• Symptoms that warrant blood testing (fatigue, low libido, reduced strength)
• Required laboratory confirmation before treatment
• Potential benefits: improved energy, sexual function, bone health
• Potential risks: polycythaemia, prostate effects, cardiovascular considerations
• Ongoing monitoring requirements (PSA, haematocrit, lipid profile)
• Situations where prescription requests may be declined
Doctors assess morning testosterone levels, symptom profile, cardiovascular risk, prostate history, sleep apnoea, fertility plans, and baseline blood results before prescribing. Testosterone is not recommended for normal ageing without confirmed deficiency. Some patients require in-person examination or specialist referral.
This episode reflects how hormone therapy decisions are reviewed within structured medical assessment in European telemedicine at Mobi Doctor.
Read the full medical guide here:
https://www.mobidoctor.eu/blog/testosterone-therapy-potential-benefits-and-risks-as-you-age